Buy ADVAIR HFA 21 ug/1 fluticasone propionate and salmeterol xinafoate

ADVAIR HFA 21 ug/1 is a combination inhaler containing fluticasone propionate and salmeterol xinafoate. It is designed for respiratory use and is commonly used for managing asthma and chronic obstructive pulmonary disease (COPD). This metered aerosol provides precise dosing for effective respiratory support.

Strength

21 ug/1

Pack Size

1 INHALER in 1 CARTON (0173-0715-22) / 60 AEROSOL, METERED in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

ADVAIR HFA 21 ug/1 is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The combination of fluticasone propionate, a corticosteroid, and salmeterol xinafoate, a long-acting beta-agonist, works to reduce inflammation and relax the muscles in the airways. This helps to improve breathing and manage symptoms associated with these respiratory conditions. People often ask, 'What is ADVAIR HFA used for?' and the answer is that it is typically prescribed for long-term control of asthma and COPD symptoms.

Side Effects

Common effects of using ADVAIR HFA 21 ug/1 may include a reduction in airway inflammation and improved breathing. Users might experience fewer asthma attacks or COPD exacerbations. Some individuals may also notice a decrease in wheezing and shortness of breath. As with any medication, individual responses can vary, and it is important to follow the advice of a healthcare provider.

Precautions & Warnings

ADVAIR HFA 21 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should be aware of potential side effects and discuss any concerns with their healthcare provider. Regular monitoring may be necessary to ensure the medication is working effectively and safely. Always store the inhaler properly to maintain its efficacy.

Avoid Interactions

ADVAIR HFA 21 ug/1 may interact with other medications, including beta-blockers, which can reduce the effectiveness of salmeterol. It is also important to avoid using other long-acting beta-agonists simultaneously, as this can increase the risk of side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Additionally, alcohol and certain foods may affect how the body responds to the medication.

References

Frequently Asked Questions

ADVAIR HFA 21 ug/1 is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

ADVAIR HFA 21 ug/1 should be administered via inhalation, following the instructions provided by a healthcare professional.

Common side effects may include throat irritation, hoarseness, and headache. Some users may also experience tremors or increased heart rate.

ADVAIR HFA 21 ug/1 may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

ADVAIR HFA 21 ug/1 should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.